The Minimal Clinically Important Difference: A Review of Clinical Significance

最小临床重要差异 医学 标准化 临床试验 结果(博弈论) 临床研究设计 医学物理学 随机对照试验 统计 外科 数学 病理 计算机科学 操作系统 数理经济学
作者
David A. Bloom,Daniel J. Kaplan,Edward S. Mojica,Eric J. Strauss,Guillem Gonzalez‐Lomas,Kirk A. Campbell,Michael J. Alaia,Laith M. Jazrawi
出处
期刊:American Journal of Sports Medicine [SAGE Publishing]
卷期号:51 (2): 520-524 被引量:91
标识
DOI:10.1177/03635465211053869
摘要

The minimal clinically important difference (MCID) is a term synonymous with orthopaedic clinical research over the past decade. The term represents the smallest change in a patient-reported outcome measure that is of genuine clinical value to patients. It has been derived in a myriad of ways in existing orthopaedic literature.To describe the various modalities for deriving the MCID.Narrative review; Level of evidence, 4.The definitions of common MCID determinations were first identified. These were then evaluated by their clinical and statistical merits and limitations.There are 3 primary ways for determining the MCID: anchor-based analysis, distribution-based analysis, and sensitivity- and specificity-based analysis. Each has unique strengths and weaknesses with respect to its ability to evaluate the patient's clinical status change from baseline to posttreatment. Anchor-based analyses are inherently tied to clinical status yet lack standardization. Distribution-based analyses are the opposite, with strong foundations in statistics, yet they fail to adequately address the clinical status change. Sensitivity and specificity analyses offer a compromise of the other methodologies but still rely on a somewhat arbitrarily defined global transition question.This current concepts review demonstrates the need for (1) better standardization in the establishment of MCIDs for orthopaedic patient-reported outcome measures and (2) better study design-namely, until a universally accepted MCID derivation exists, studies attempting to derive the MCID should utilize the anchor-based within-cohort design based on Food and Drug Administration recommendations. Ideally, large studies reporting the MCID as an outcome will also derive the value for their populations. It is important to consider that there may be reasonable replacements for current derivations of the MCID. As such, future research should consider an alternative threshold score with a more universal method of derivation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qingmao完成签到,获得积分10
刚刚
李健应助钟薛菘采纳,获得10
1秒前
坚定笑蓝完成签到,获得积分10
1秒前
晓晓发布了新的文献求助10
2秒前
小QQ应助科研通管家采纳,获得10
3秒前
3秒前
bkagyin应助科研通管家采纳,获得10
3秒前
在水一方应助科研通管家采纳,获得10
3秒前
归尘应助科研通管家采纳,获得30
3秒前
归尘应助科研通管家采纳,获得30
3秒前
啦啦啦应助科研通管家采纳,获得10
3秒前
所所应助科研通管家采纳,获得10
3秒前
柔弱谷云应助科研通管家采纳,获得10
3秒前
慕青应助科研通管家采纳,获得10
3秒前
科研通AI2S应助科研通管家采纳,获得30
4秒前
Jasper应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
李爱国应助ss采纳,获得10
5秒前
五行发大水完成签到,获得积分10
5秒前
6秒前
科研通AI6.3应助小9采纳,获得10
6秒前
7秒前
古炮完成签到,获得积分10
7秒前
8秒前
ding应助正直听白采纳,获得10
9秒前
9秒前
带头大哥应助威武从寒采纳,获得200
9秒前
tt发布了新的文献求助10
11秒前
可爱的函函应助我爱科研采纳,获得30
11秒前
xx发布了新的文献求助10
12秒前
小马甲应助晓晓采纳,获得10
13秒前
郝炫发布了新的文献求助30
13秒前
诚心怀柔发布了新的文献求助10
13秒前
cyh应助陶醉大侠采纳,获得10
14秒前
15秒前
15秒前
ding应助luck采纳,获得10
15秒前
guoer完成签到,获得积分10
16秒前
tt完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
機能性マイクロ細孔・マイクロ流体デバイスを利用した放射性核種の 分離・溶解・凝集挙動に関する研究 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Continuing Syntax 1000
Harnessing Lymphocyte-Cytokine Networks to Disrupt Current Paradigms in Childhood Nephrotic Syndrome Management: A Systematic Evidence Synthesis 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6259176
求助须知:如何正确求助?哪些是违规求助? 8081321
关于积分的说明 16884668
捐赠科研通 5331001
什么是DOI,文献DOI怎么找? 2837896
邀请新用户注册赠送积分活动 1815282
关于科研通互助平台的介绍 1669210